Vimarsana
Biggest News Aggregation in the World

Page 46 - Clinical News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Clinical. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Clinical Today - Breaking & Trending Today

Regulations and Ethics of Clinical Trials - Vimarsana News

Regulations and Ethics of Clinical Trials

Clinical research is designed to improve human health and increase our understanding of human biology, ultimately leading to significant advances in scientific knowledge.

Axiom Exhibiting at Clinical Operations in Oncology Trials - Vimarsana News

Axiom Exhibiting at Clinical Operations in Oncology Trials

TORONTO, July 18, 2022 (GLOBE NEWSWIRE) -- Axiom Real-Time Metrics ("Axiom"), the premier provider of unified eClinical solutions and services focused on...

Prevention, identification and management of malnutrition in older people in the community - Vimarsana News

Prevention, identification and management of malnutrition in older people in the community

Prevention, identification and management of malnutrition in older people in the community

Source: rcni.com
Brandessence Market Research And Consulting Private Limited: At 13.5% CAGR, eClinical Solution Market is Expected to Reach USD 19.69 Billion by 2028 - Vimarsana News

Brandessence Market Research And Consulting Private Limited: At 13.5% CAGR, eClinical Solution Market is Expected to Reach USD 19.69 Billion by 2028

LONDON, June 22, 2022 /PRNewswire/ -- eClinical Solution Market is valued at USD 8.12 Billion in 2021 and is expected to reach USD 19.69 Million by 2028 with a CAGR of 13.5% over the forecast

Milestone Achievement for Consortium seeking Solutions against AMR - Vimarsana News

Milestone Achievement for Consortium seeking Solutions against AMR

The European-funded GNA NOW Consortium and Nosopharm, a biotechnology company exploring unconventional sources of antibiotics with potential in the fight against antimicrobial resistance, have announced a milestone development following completion and positive results of toxicology studies for a first-in-class antibiotic for the treatment of multidrug-resistant infections. Click to read more...